Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0002083206-26-000007

Chief Financial Officer sold 4,117 shares at $4.91 ($20,203)

From the SEC's structured data for this filing

Trades in this filing

Tamayo Louis Edward · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-18 Sale : show line 1 in the form −4,117 $4.91 $20,203 92,907 D
Open-market sales · 4,117 sh · avg $4.91 · $20,203
Loading xslF345X06/form4-08192026_050809.xml…